Vetter Completes Development and IT Facility
PTSM: Pharmaceutical Technology Sourcing and Management
Vetter announces completion of multi-functional building for development service and IT functions.
Vetter announced on Jan. 28, 2016 that the company’s Schuetzenstrasse multi-functional building in Ravensburg, Germany, has been completed on schedule and departments critical to its operation have started to move in. The €29 million investment is part of a €300 million total investment strategy announced by the company in September 2015 for further development to its manufacturing sites.
The continued demand by large and small customers for enhanced drug development services, as well as the need for ever-more future-oriented sophisticated IT systems to protect their data, created the need for the new facility, the company reported in a press statement.
The 91,500-sq ft, six-story building contains non-cGMP laboratories for development support, laboratory space for microbiological analysis, office workplaces for Vetter Development Service and IT, and a data processing center with enhanced security systems, including a safety cell that protects technology and data from external physical hazards in the event of an emergency.
Source: Vetter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
